Naringenin Supplementation in Bone Fracture Patients
In plain words A study of naringenin in people 18 to 60, run by Shahid Beheshti University of Medical Sciences. It plans to enroll about 70 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 60. Conditions: Bone Fractures.
- Candidate for orthopedic surgery for bone fractures of the lower limbs,
- Ambulatory without assistance for a minimum of two months prior to the fracture.
- Not having undergone amputation of the lower limbs.
- Not suffering from liver cirrhosis.
2 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
The daily ingestion of capsules containing naringenin; Placebo
Registered summary
Fractures of the lower extremities represent a significant proportion of injuries sustained by polytrauma patients, with a notable association with prolonged hospitalization, chronic disability, and impaired physical functioning. The occurrence of surgical site infections (SSI) represents a significant threat to the efficacy of osteosynthesis procedures. As with other traumas and surgical procedures, the secretion of inflammatory mediators is markedly elevated in this cohort of patients following surgery. The full summary is on the listing.
Where, as registered
No US site; Iran (1).